Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Recipient : Panion and Bf Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ferric Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hyperphosphatemia.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
June 13, 2019
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Recipient : Panion and Bf Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
